Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo - A multicentre controlled study

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 7, 2007, Pages 956-963

  Casacci, M ^a   Thomas, P ^a   Pacifico, A ^b   Bonnevalle, A ^a   Paro Vidolin, A ^b   Leone, G ^b  

^a UNIV LILLE   (France)

^b SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

Monochromatic excimer laser; Monochromatic excimer light; Narrowband ultraviolet B; Vitiligo

Indexed keywords

ANTIOXIDANT; CALCIPOTRIOL; CORTICOSTEROID; PSORALEN;

ADOLESCENT; ADULT; ARTICLE; BLISTER; BULLOUS SKIN DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; ERYTHEMA; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MULTICENTER STUDY; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; PUVA; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SKIN PIGMENTATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ULTRAVIOLET B RADIATION; VITILIGO;

ADOLESCENT; ADULT; FEMALE; HUMANS; LASERS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; VITILIGO;

EID: 34547110558     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02151.x     Document Type: Article

References (34)

1. Castanet J, Ortonne JP. Pathophysiology of vitiligo. Clin Dermatol 1997; 15: 845-851.
2. Grimes PE. White patches and bruised souls. Advances in the pathogenesis and treatment of vitiligo. J Am Acad Dermatol 2004; 51: 5-7.
3. Njoo MD, Westerhof W. Vitiligo. Pathogenesis and treatment. Am J Clin Dermatol 2001; 2: 167-181.
4. Kovacs SO. Vitiligo. J Am Acad Dermatol 1998; 38: 647-666.
5. Gauthier Y, Andre MC, Taieb A. A critical appraisal of vitiligo etiologic therapies. Is melanocyte loss a malanocytorrhagy? Pigment Cell Res 2003; 16: 322-332.
6. Westerhof W, Nieuweboer-Krobotova L, Mulder PGH, Glazenburg EJ. Left-right comparison study of the combination of fluticasone propionate and UVA versus either fluticasone propionate or UVA alone for the long-term treatment of vitiligo. Arch Dermatol 1999; 135: 1061-1066.
7. Njoo MD, Westerhof W, Bos JD, Bossuyt PM. A systemic review of autologous transplantation methods in vitiligo. Arch Dermatol 1998; 134: 1543-1549.
8. Chen YF, Yang PY, Hu DN et al. Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: Analysis of 120 cases. J Am Acad Dermatol 2004; 51: 68-74.
9. Kanwar AJ, Dogra S, Parsad D. Topical tacrolimus for treatment of childhood vitiligo in Asians. Clin Exp Dermatol 2004; 29: 589-592.
10. Roelandts R. Photo (chemo) therapy for vitiligo. Photodermatol Photoimmunol Photomed 2003; 19: 1-4.
11. Horikawa T, Norris DA, Johnson TW et al. DOPA-negative melanocytes in the outer root sheath of human hair follicles express premelanosomal antigens but not a melanosomal antigen or the melanosome-associated glycoproteins tyrosinase, TRP-1, and TRP-2. J Invest Dermatol 1996; 106: 28-35.
12. Fitzpatrick TB. Mechanisms of phototherapy of vitiligo. Arch Dermatol 1997; 133: 1591-1592.
13. Morelli J, Kincannon J, Yohn J et al. Leukotrienes C4 and TGF-α are stimulators of human melanocyte migration in vitro. J Invest Dermatol 1992; 98: 290-295.
14. Duthie MS, Kimber I, Norval M. The effects of ultraviolet radiation on the human immune system. Br J Dermatol 1999; 140: 995-1009.
15. Kwok YKC, Anstey AV, Hawk JLM. Psoralen photochemotherapy (PUVA) is only moderately effective in widespread vitiligo: A 10-year retrospective study. Clin Exp Dermatol 2002; 27: 104-110.
16. Antoniou C, Schilpis H, Michas T et al. Vitiligo therapy with oral and topical phenylalanine with UVA exposures. Int J Dermatol 1989; 28: 545-547.
17. Grimes PE. New insights and new therapies in vitiligo. JAMA 2005; 293: 730-735.
18. Passeron T, Ostovari N, Zakaria W et al. Topical tacrolimus and the 308 nm excimer laser: A synergistic combination for the treatment of vitiligo. Arch Dermatol 2004; 140: 1065-1069.
19. Leone G, Pacifico A, Iacovelli P et al. Tacalcitol and narrow band phototherapy in patients with vitiligo. Clin Exp Dermatol 2006; 31: 200-205.
20. Berneburg M, Rocken M, Benedix F. Phototherapy with narrowband vs broadband UVB. Acta Derm Venereol 2005; 85: 98-108.
21. Ibbotson SH, Bilsland D, Cox NH et al. An update and guidance on narrowband ultraviolet B phototherapy: A British Photodermatology Group Workshop Report. Br J Dermatol 2004; 151: 283-297.
22. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL01) UVB radiation therapy. J Am Acad Dermatol 2000; 42: 245-253.
23. Spencer JM, Nossa R, Ajmeri J. Treatment of vitiligo with the 308 nm excimer laser: A pilot study. J Am Acad Dermatol 2002; 46: 727-731.
24. Taneja A, Trehan M, Taylor CR. 308 nm excimer laser for the treatment of localized vitiligo. Int J Dermatol 2003; 42: 658-662.
25. Leone G, Lacovelli P, Paro Vidolin A, Picardo M. Monochromatic excimer light 308 nm in the treatment of vitiligo: A pilot study. J Eur Acad Dermatol Venereol 2003; 17: 531-537.
26. Westerhof W, Nieuweboer-Krobotowa L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 1997; 133: 1525-1528.
27. Hadi SM, Spencer JM, Lebwhol M. The use of the 308 nm excimer laser for the treatment of vitiligo. Dermatol Surg 2004; 30: 983-986.
28. Hofer A, Hassan AJ, Legat FJ, Kerl H, Wolf P. Optimal weekly frequency of 308 nm excimer laser treatment in vitligo patients. Br J Dermatol 2005; 152: 981-985.
29. Trehan M, Taylor CR. High dose 308 nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol 2002; 46: 732-737.
30. Bianchi B, Campolmi P, Mavilla L et al. Monochromatic excimer light (308 nm): An immunohistochemical study of cutaneous T cells and apoptosis related molecules in psoriasis. J Eur Acad Dermatol Venereol 2003; 17: 408-413.
31. Novak Z, Bonis B, Baltas E et al. Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow band ultraviolet B. J Photochem Photobiol B 2002; 67: 32-38.
32. Baltas E, Csoma Z, Iynacz F et al. Treatment of vitiligo with the 308 nm xenon chloride excimer laser. Arch Dermatol 2002; 138: 1619-1620.
33. Esposito M, Soda R, Costanzo A, Chimenti S. Treatment of vitiligo with the 308 nm excimer laser. Clin Exp Dermatol 2004; 29: 133-137.
34. Hong SB, Park HH, Lee MH. Short term effects of 308 nm xenon chloride excimer laser and narrow band ultraviolet B in the treatment of vitiligo: A comparative study. J Korean Med Sci 2005; 20: 273-278.